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Abstract It is suggested that gastric mucins, and in par-
ticular some speciﬁc glycan structures that can act as car-
bohydrate receptors, are involved in the interactions with
Helicobacter pylori adhesins. The main aim of our study
was to evaluate glycosylation pattern of glycoproteins of
gastric juice before and at the end of eradication therapy.
Gastric juices were taken from 13 clinical patients and
subjected to analysis. Pooled fractions of the void volume
obtained after gel ﬁltration were subjected to ELISA tests.
To assess the relative amounts of carbohydrate structures,
lectins and monoclonal antibodies were used. Changes in
the level of MUC 1 and MUC 5AC mucins and of carbo-
hydrate structures, which are suggested to be receptors
for Helicobacter pylori adhesins, were observed by the
end of the eradication treatment. Our results support
the idea about the involvement of MUC 5AC and MUC 1
with some speciﬁc sugar structures in the mechanism of
Helicobacter pylori infection.
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Introduction
It is believed that gastric mucus gel layer forms an effec-
tive protective barrier against various pathogens, such as
Helicobacter pylori, the major etiological agent of chronic
gastritis, peptic ulcers, and gastric cancers [1–3]. The main
components of mucus are the heavily O-glycosylated pro-
teins known as mucins. Three of them are present in human
stomach. MUC 5AC and MUC 6 mucins are all secreted
into gastric juice; the former being expressed by the surface
epithelium and the latter by the deeper antrum gland epi-
thelium [4]. In addition, the epithelial membrane-associ-
ated MUC 1 mucin is also present in the stomach [5]. The
glycans in mucins are mainly O-linked with blood group
antigens often present terminally. Mucin-type oligosac-
charides are structurally very diverse; the glycans in the
same molecule can exhibit a high degree of subtle varia-
tions in their structure depending on dynamic physiological
and pathological biochemical conditions that exist in the
body at the time when the structures are formed [6]. The
glycosyltransferases expressed by the individual determine
glycan proﬁles of mucins in that individual [7].
Helicobacter pylori can colonize gastric epithelium by
interactions with carbohydrates receptors [8]. Lewis b
structure is one of the known receptors for bacterial
adhesins (BabA–the blood group antigen–binding adhesin),
and it is considered that MUC 5AC mucin is the main
carrier of this structure [8, 9]. Some other glycoform
structures (e. g. H type 1 structure, sialyl Lewis x) are also
suggested to be implicated in binding with H. pylori
adhesins [10–12]. It has been recently proposed that apart
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receptors for bacterial adhesins and can be involved in
development of infection [7, 13, 14]. There are suggestions
that changes in glycoforms can affect the protective func-
tions of gastric mucins and H. pylori colonization. It is
postulated that alterations that occur during H. pylori
infection are completely reversed after eradication [14].
The main aim of our study was to check whether there
are changes in the pattern of glycosylation of the mucins of
gastric juice before and after eradication of H. pylori. We
assumed that carbohydrates present in gastric juice origi-
nate from gastric mucosa. Among them, there are secreted
MUC 5AC mucin and soluble form of membrane-bound
MUC 1. We suppose a parallel relationship between MUC
1 cell membrane expression and its shedding to gastric
juice. To test the changes in glycosylation, we used ELISA
method with monoclonal antibodies against gastric mucins
and some glycan epitopes and biotinylated lectins with
well-known sugar speciﬁcity.
Materials and methods
Patients and specimens
Thirteen Helicobacter pylori–infected patients with duode-
nal ulcers (9 men, 4women; agerange 24–60,mean age44),
hospitalized in the Department of Medicine and Gastroen-
terology of Regional Hospital of Białystok, Poland,
were included in the study. Each patient was treated for
2 weeks with oral administration of omeprazole (2 9 20 mg
per day), amoxiciline (2 9 1,000 mg), and tynidazole
(2 9 500 mg). All subjects were on standard hospital diet
served for the peptic ulcer patients. The tested gastric juices
were taken before and on days 11–13 of the treatment. They
werecollectedbyaspirationfor15 minwithagastriccatheter
inserted through the nares. The procedure was performed
in the morning hours after overnight fasting. At the ﬁrst
gastric test, no drugs were allowed for at least 14 days, at the
second gastric test the last doses of the drugs (omeprazole,
amoxicillin, and tinidazole) were taken in the evening pre-
ceding the day of the examination.
The presence of the bacterium was examined histolog-
ically and by urease test with gastric cells scraped under
endoscopic examination. It was done before and at the end
of the treatment. The eradication therapy was successful in
all the patients at the second endoscopy assessment.
Enzyme-linked immunosorbent assay
The juice was initially treated as described before [15].
High molecular mass material obtained in the void volume
after gel ﬁltration was subjected to further analysis. To
assess relative amounts of carbohydrate structures in
examined material, ELISA tests with monoclonal anti-
bodies and biotinylated lectins were performed. Speciﬁ-
cations of antibodies employed in this study are listed in
Table 1. For carbohydrate speciﬁcity of lectins, see
Table 2. Samples of gastric juices were diluted to the
identical protein concentration 5 lg/mL, and aliquots (50
lL) were coated onto microtiter plates (NUNC F96;
Maxisorp, Roskilde, Denmark) at room temperature over-
night. The protein content was determined using bicinch-
oninic acid [16]. The plates were washed 3 times (100 lL)
with PBS, pH 7.4, 0.05% Tween (PBS-T; washing buffer)
between all ensuing steps. Unbound sites were blocked
with 100 lL of 1% blocking reagent for ELISA (Roche
Diagnostics, Mannheim, Germany) for 1 h. The microtiter
plates were incubated with 100 lL of biotinylated lectins
(1 h) diluted to 0.5 lg/mL in PBS-T, 1% bovine serum
albumin, BSA (Sigma, St Luis, MO, USA). Some lectin
solutions were supplemented with metal cations: DSA,
UEA, SNA, LTA, PNA, and GNA with 0.1 mmol/L CaCl2;
MAA and VVA with 0.1 mmol/L CaCl2 and 0.01 mmol/L
MnCl2. Plates were then incubated with 100 lL of horse-
radish peroxidase avidin D (Vector, Burlingame, CA,
USA) (1 : 2 500) in PBS-T, 1% BSA for 1 h. Next, plates
were washed 4 times in PBS, and the colored reaction was
developed by incubating with 2,20-azino-bis(3-ethyl-
benzthiazoline-6-sulfonic acid) (ABTS)–liquid substrate
Table 1 Sources of antibodies
used in this study
Antibody Clone Source Final
dilution
MUC 1 (anti-human episialin–EMA) GP1.4 SIGMA 1:400
MUC 5AC 45M1 SIGMA 1:400
Lewis b LWB01 LAB VISION 1:1,500
Sialyl Lewis x KM93 CHEMICON 1:500
H type 1 17-206 ABCAM 1:500
Horseradish peroxidase–conjugated rabbit anti-mouse IgG SIGMA 1:1,500
Horseradish peroxidase–conjugated goat anti-mouse IgM
(l-chain speciﬁc)
SIGMA 1:1,500
82 Clin Exp Med (2011) 11:81–88
123for horseradish peroxidase (Sigma, St Luis, MO, USA).
Absorbance at 405 nm was measured after 30–45 min. For
analysis with monoclonal antibodies (diluted in washing
buffer, 1% BSA), the plates were coated with 100 lLo f
antibody for 1 h. Next, they were incubated with secondary
antibody, horseradish peroxidase–conjugated anti-mouse
IgG (for anti-MUC 1, MUC 5AC, Lewis b, and H type 1
structures) or anti-mouse IgM (for anti-sialyl Lewis x
structure). The colored reaction was developed as men-
tioned earlier. As controls wells with no gastric juices were
used.
Statistical analyses
The relative amounts of examined structures (based on
absorbance at 405 nm obtained from ELISA tests) were
subjected to statistical analysis (by STATISTICA 7.1
StatSoft program). All the data revealed normal distribu-
tion, and two-sided t-test was used. Statistical signiﬁcance
was assumed at P\0.05. Pearson’s correlations of two
variables (the relative amounts of MUC 1 and MUC 5AC
mucins before and at the end of the treatment versus the
relative amounts of examined carbohydrate structures
before and at the end of the therapy) were calculated.
The study was approved by the Institutional Ethical
Committee and conducted according to the principles of
the Declaration of Helsinki. Informed consent was obtained
from all the patients.
Results
Juices from 13 patients were divided into two groups:
before eradication and at the end of eradication therapy
(11–13 day of the treatment). High molecular mass mate-
rial of void volume obtained after gel ﬁltration of gastric
juices was taken for glycan analysis.
Glycans of all gastric juices examined revealed reac-
tivity with monoclonal antibodies (Fig. 1) and lectins
(Fig. 2) employed in this study. The analysis of the inter-
actions of gastric juices with speciﬁc anti-MUC 1 and
MUC 5AC monoclonal antibodies revealed higher levels of
both mucins in juices at the end of eradication treatment. In
case of MUC 1, the difference was statistically signiﬁcant
(P = 0.000066) (Fig. 3).
The relative amounts of speciﬁc carbohydrate structures
Lewis b, sialyl Lewis x, and H type 1 recognized by
monoclonal antibodies were found to be higher at the end
of eradication therapy. For sialyl Lewis x and H type 1
Table 2 The major binding
speciﬁcities of used lectins
Origin and used abbreviation of lectin Binding preference
Areulia auranta (AAA) Fuca1-6GlcNAc; Fuca1-2Gal; Fuca1-3GlcNAc [25]
Ulex europaeus (UEA) Fuca1-2Gal; Fuca1-3GlcNAc [26]
Lotus tetragonolobus (LTA) Fuca1-3GlcNAc [27]
Maackia amurensis (MAA) NeuAca2-3Gal [28]
Sambucus nigra (SNA) NeuAca2-6Gal/GalNAc [29]
Arachis hypogaea (Peanut) (PNA) Galb1-3GalNAc (T-antigen) [30]
Vicia villosa (VVA) GalNAc (Tn-antigen) [31]
Datura stramonium (DSA) Galb1-4GlcNAc; GlcNAc [32]
Narcissus pseudonarcissus (NPA) a-1,6 mannose residues [33]
Galanthus nivalis (GNA) a-1,3 mannose residues [34]
Fig. 1 Reactivity with monoclonal antibodies (at 405 nm). a juices
before eradication treatment (n = 13); b juices at the end of
eradication therapy (n = 13). The points are connected for those that
belong to the same sample
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123structures, the differences were statistically signiﬁcant
(P = 0,00208 and 0.00209 for sialyl Lewis x and H type 1,
respectively) (Fig. 3).
Fucosylation proﬁle was examined by LTA, UEA, and
AAA lectins. The lowest amount was observed for Fuc a 1-
3 bond. The relative amounts of all fucosylated structures
were higher at the end of eradication treatment. The dif-
ferences were statistically signiﬁcant for AAA and UEA
lectins (P = 0.000124 and 0.03475, respectively) (Fig. 4).
SNA and MAA are lectins speciﬁc for sialic acid. The
analysis of interactions of these lectins with glycoproteins
of juices showed a little higher amount of SA a 2–3
than SA a 2–6 linkage. In both cases, higher level of
these speciﬁc structures was observed at the end of the
treatment with statistically signiﬁcant difference for SNA
(P = 0.003475) (Fig. 4).
PNA and VVA lectins recognize T and Tn antigens,
respectively. The results of our analyses revealed almost
the same level of binding of both lectins to glycans present
in two examined groups of juices (Fig. 4).
The relative amounts of complexes formed between
sugar structures of gastric juices and DSA lectin (speciﬁc
for Gal b 1–4 GlcNAc-R and GlcNAc-R linkages) were
signiﬁcantly higher after eradication treatment (P = 0.011)
(Fig. 4).
NPA and GNA are lectins with speciﬁcity toward a 1–6
and a 1–3 linked mannose, present especially in N-glyco-
proteins. The relative amounts of above linkages were low
in comparison with bonds revealed by other lectins, with
very similar level before and at the end of eradication
treatment (Fig. 4).
Pearson’s correlations between the amounts of exam-
ined sugar structures and the amounts of MUC 5AC and
MUC 1 mucins in juices before treatment and at the end of
eradication therapy were calculated. Mostly, the correla-
tions between mentioned structures in two examined
groups of juices were rather low. Moderate and high cor-
relations in both groups of juices were found between the
amounts of MUC 1 and H type 1 structure (r = 0.39 and
0.87 for juice before and at the end of the treatment,
respectively). Such positive correlations were also revealed
between MUC 5AC and structure recognized by SNA
lectin (r = 0.47 and 0.46 for juice before and at the end of
the treatment) and between MUC 5AC and structure rec-
ognized by LTA and UEA lectins (r = 0.8 and 0.48 for
LTA and 0.39 and 0.32 for UEA for juice before and at the
Fig. 2 Reactivity with lectins (at 405 nm). a juices before eradica-
tion treatment (n = 13); b juices at the end of eradication therapy
(n = 13). The points are connected for those that belong to the same
sample
Fig. 3 Comparison of
reactivity with monoclonal
antibodies in juices before and
the end of eradication therapy.
Bars represent the mean ± SD
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123end of the eradication therapy, respectively). In case of
MUC 5AC and Lewis b structure, correlations were also
positive in both juices (r = 0.27 and 0.46). The values of
all coefﬁcients together with their statistical signiﬁcances
are summarized in Table 3.
Discussion
Analyses of carbohydrates of gastric juices before and at
the end of eradication therapy revealed alterations caused
likely by H. pylori infection. Because the examined
material was taken from the void volume after gel ﬁltra-
tion, we assume that analyzed structures originate mostly
from high molecular mass mucins. Two mucins, MUC 1
and MUC 5AC, which are suggested to be involved in the
mechanism of the infection, were analyzed. MUC 5AC is
secretory one and can be normally present in gastric juice.
MUC 1 is membrane-bound mucin, but it can be cleaved
by host cell proteases and released to juice from gastric cell
surface [17]. The higher level of both mucins was observed
at the end of the treatment, which is in accordance with the
results of some other investigations which revealed that H.
pylori inhibits total mucin synthesis in gastric epithelial
cells [18–20]. It is suggested that protective ability of
gastric mucins may depend largely on their oligosaccharide
chains. Alterations in the glycosylation pattern induced by
the infection can impair the protective function of mucins.
An increased level of MUC 1 mucin after eradication
treatment was also observed in our earlier investigations
when we examined this structure and also Lewis b and a
blood group antigens using Western blotting and densi-
tometry [15, 21].
Our results revealed increased level at the end of erad-
ication therapy for only of those carbohydrate structures
that are proposed to be involved in the interactions with
H. pylori adhesins. The expression of fucosylated glycans
was examined by anti-Lewis b, anti-H type 1 monoclonal
antibodies, and AAA, UEA, and LTA lectins. Fuc a 1–2
linkage, which seems to be the most abundant, is present
especially in peripheral Gal residues, which can be easily
available for bacterial adhesins. Fuc a 1–2 bond is present
in Lewis b and H type 1 structures, and these glycans were
also observed in higher level at the end of the treatment.
Therefore, our results support hypothesis about involve-
ment of Lewis b and H type 1 structures in interactions
with H. pylori [7–9, 11]. The depletion of these antigens in
the infectious state might promote infection by enhancing
the access of the bacterium to the epithelial surface [18].
Another explanation can also be taken into account. The
decreased level of these possible bacterial receptors that
can be located in MUC 1 and MUC 5AC mucin is sug-
gested to be a kind of host defense. Some authors propose
hypothesis with MUC 1 as a releasable decoy ligand for H.
pylori that can be released from cell surface together with
the adhered bacterium [7, 18]. Carbohydrate structures of
MUC 1 mucin that possess long ﬁlamentous extracellular
domain are considered to be the point of ﬁrst direct contact
between host cells and pathogenic organisms that penetrate
the secreted mucus layer.
It is said that sialylated glycan structures are not typical
for gastric mucins; they account for only about 3% of the
total oligosaccharides (present in MUC 5AC mucin) [18],
but they are also considered by some authors as potential
receptors for bacterial adhesins [10, 12]. Sialylated forms
are characteristic in H. pylori–infected specimens, and they
decrease after eradication [10]. Surprisingly, in our study
for both examined kinds of linkages, SA a 2–3 and SA a
2–6, the increased level in the recovered state was revealed.
It is likely that high level of sialylation is due to the
presence of highly sialylated, salivary MUC 5B mucin in
gastric juice [22]. However, it was not explored in our
study. The increase in sialyl Lewis x structure (with a SA
2–3 bond; recognized by monoclonal antibody) at the end
Fig. 4 Comparison of
reactivity with lectins in juices
before and the end of
eradication therapy. Bars
represent the mean ± SD
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SA a 2–3 bond detected by MAA lectin. This discrepancy
can be explained by higher speciﬁcity of monoclonal
antibodies than lectins during detection. Sialylation
through a 2–6 bond is typical especially for short core
carbohydrate structures and in our experiments was
detected in low level, although with slight increase at the
end of the therapy.
Gal b 1-4 GlcNAc structure (detected by DSA lectin),
typical for O-glycosylated mucins, found also in sialyl
Lewis x glycoform, was more abundant at the end of
eradication treatment. This result is in accordance with
general tendency of the increased level of examined mucins
and glycoforms involved in interactions with H. pylori at
the end of the treatment.
We observed no inﬂuence of the infection on the levels
of short Tn and T carbohydrate structures. This result
conﬁrms the proposal that H. pylori inﬂuences only the
peripheral sugar structures. Mannose residues, not typical
in O-glycosidic chains, were detected in very low levels.
These probably originate from rare N-glycosidic oligo-
saccharides that can be present in mucins [17].
As the mechanism of H. pylori infection has not been
elucidated thoroughly, it is difﬁcult to explain the mecha-
nism of alterations induced by the bacterium. One possible
explanation is that H. pylori can change the expression of
genes involved in glycan synthesis such as transferases,
crucial for the biosynthesis of potential bacterial receptors
[18]. Interesting hypothesis about kind of relationship
between two mucins (MUC 5AC and MUC 1) likely
involved in the mechanism of infection has been proposed.
MUC 5AC as more abundant one may at ﬁrst catch Helico-
bacter pylori and then deliver it to the membrane-associated
MUC 1 mucin. This mucin can cause signal transduction
over the epithelial barrier and act as a releasable decoy. In
this way, mucins together with the bacterium can be ﬂushed
away (Fig. 5)[ 7, 23]. The level of both mucins, with some
speciﬁc sugar structures, acting as receptors for bacterial
adhesins, decreases. These alterations are completely
reversed after eradication [14].
Table 3 Pearson’s coefﬁcients
calculated for two variables (the
relative amounts of MUC 1 and
MUC 5AC mucins before and at
the end of the treatment versus
the relative amounts of
examined carbohydrate
structures before and at the end
of the therapy)
Degrees of correlations:
Pearson’s coefﬁcient
r = 1—perfect correlation;
0.75 B r\1—high degree of
correlation; 0.25 B r\0.75—
moderate degree of correlation;
0\r\0.25—low degree of
correlation; -1 B r B 0—no
correlation
* Denotes statistically
signiﬁcant differences
(P\0.05)
Pearson’s coefﬁcient (r)
Juices before eradication
treatment
Juices at the end of
eradication treatment
MUC 1 vs. Lewis b 0.44* 0.18*
sialyl Lewis x 0.75* -0.07*
H type 1 0.39 0.87*
Structure recognized by MAA -0.11* -0.74*
Structure recognized by SNA 0.3* 0.13
Structure recognized by AAA 0.18* 0.17*
Structure recognized by UEA 0.23* 0.31*
Structure recognized by LTA 0.55* -0.14
Structure recognized by PNA -0.24* -0.46*
Structure recognized by VVA -0.37* -0.48*
Structure recognized by DSA 0.11* -0.4
Structure recognized by NPA 0.49 -0.32*
Structure recognized by GNA 0.62 -0.26
MUC 5AC vs. Lewis b 0.27* 0.46*
sialyl Lewis x 0.46 0.011*
H type 1 0.5* 0.13
Structure recognized by MAA 0.66* -0.13*
Structure recognized by SNA 0.47 0.46
Structure recognized by AAA -0.3* -0.16*
Structure recognized by UEA 0.39* 0.32*
Structure recognized by LTA 0.8 0.48
Structure recognized by PNA -0.26* 0.033*
Structure recognized by VVA 0.18* 0.16*
Structure recognized by DSA 0.005 -0.26
Structure recognized by NPA -0.2 -0.3*
Structure recognized by GNA 0.24 -0.28
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tures also cannot be excluded. It is said that pH change
(after omeprazole treatment) in Helicobacter pylori envi-
ronment can result in its afﬁnity to mucins, and bacteria
cannot remain efﬁciently bound to mucus and are ﬂushed
away [12, 15, 24]. However, this was not examined in the
present study.
From our results, we are not able to tell which of the
glycan epitopes are present in which mucin. We can only
suggest that H type 1 structure comes mostly from MUC 1
mucin as correlations between them in both groups of
patients examined were positive (on moderate and high
level). Similar assumptions can be taken for MUC 5 AC
and Lewis b, SA a 2–6, Fuc a 1–3, and a 1–2 linkages
because of positive values of Pearson’s coefﬁcients.
However, we should emphasize that above sugar structures
can be also present in other glycoproteins not examined in
this study. So we state that our concepts should be sup-
ported by more detailed examinations.
In conclusion, the observed changes in glycosylation
pattern induced by H. pylori support the idea about the
involvement of mucins and other glycan structures in the
mechanism of the infection. We suggest that the knowledge
about the exact action of the bacterium could contribute to
looking for new therapeutic strategies.
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